Fuli Xin

743 total citations
23 papers, 548 citations indexed

About

Fuli Xin is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Fuli Xin has authored 23 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Fuli Xin's work include Nanoplatforms for cancer theranostics (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Advanced Nanomaterials in Catalysis (5 papers). Fuli Xin is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Advanced Nanomaterials in Catalysis (5 papers). Fuli Xin collaborates with scholars based in China, United States and Australia. Fuli Xin's co-authors include Xiaolong Liu, Jingfeng Liu, Zuwu Wei, Ming Wu, Zhixiong Cai, Geng Chen, Yongyi Zeng, Lei Wang, Cuiping Yao and Qiao Ke and has published in prestigious journals such as PLoS ONE, Chemical Communications and Clinical Cancer Research.

In The Last Decade

Fuli Xin

21 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuli Xin China 10 268 169 123 116 108 23 548
Ruixiang Song China 13 254 0.9× 187 1.1× 79 0.6× 68 0.6× 55 0.5× 27 811
Bai Ji China 12 215 0.8× 80 0.5× 111 0.9× 160 1.4× 81 0.8× 36 618
Man Shu China 11 121 0.5× 93 0.6× 86 0.7× 145 1.3× 60 0.6× 25 418
Wuwei Yang China 11 148 0.6× 136 0.8× 40 0.3× 124 1.1× 206 1.9× 21 614
Weixi Jiang China 15 261 1.0× 71 0.4× 54 0.4× 39 0.3× 69 0.6× 22 574
Lei Xia China 15 307 1.1× 125 0.7× 28 0.2× 121 1.0× 52 0.5× 35 703
Chihua Fang China 9 464 1.7× 95 0.6× 34 0.3× 72 0.6× 47 0.4× 40 653
Qianhui Xu China 12 256 1.0× 172 1.0× 231 1.9× 139 1.2× 25 0.2× 21 744
Boran Cheng China 15 350 1.3× 121 0.7× 205 1.7× 378 3.3× 30 0.3× 29 858
Shengxin Huang China 11 165 0.6× 65 0.4× 49 0.4× 92 0.8× 46 0.4× 17 439

Countries citing papers authored by Fuli Xin

Since Specialization
Citations

This map shows the geographic impact of Fuli Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuli Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuli Xin more than expected).

Fields of papers citing papers by Fuli Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuli Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuli Xin. The network helps show where Fuli Xin may publish in the future.

Co-authorship network of co-authors of Fuli Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Fuli Xin. A scholar is included among the top collaborators of Fuli Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuli Xin. Fuli Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Yanbing, Yuanping He, Zhen Qu, et al.. (2025). Flash nano-encapsulation of probiotics: Bolstering environmental resistance and intestinal colonization to prevent necrotizing enterocolitis. Journal of Controlled Release. 389. 114481–114481.
2.
Huang, Yanbing, Lei Ding, Yanbing Cao, et al.. (2025). Mild Photothermal Bimetallic Mesoporous Nanozyme Triggers Immunogenic Cell Death and Immune Contexture Remodeling for Precision Hepatocellular Carcinoma Treatment. Advanced Science. 12(46). e12578–e12578. 1 indexed citations
3.
Yang, Liu, Shan Qiao, Zhaoliang Su, et al.. (2025). The supporting role of Schwann cells in perineural invasion of pancreatic ductal adenocarcinoma. Frontiers in Pharmacology. 16. 1540027–1540027.
4.
Li, Hui, Yang Hao, Yu Chen, et al.. (2025). Discovery and validation of a novel dual-target blood test for the detection of hepatocellular carcinoma across stages from cirrhosis. BMC Medicine. 23(1). 278–278. 1 indexed citations
5.
Li, Jiong, Yanbing Cao, Fuli Xin, et al.. (2024). Nanozyme Decorated Metal-Organic Framework Nanosheet for Enhanced Photodynamic Therapy Against Hypoxic Tumor. International Journal of Nanomedicine. Volume 19. 9727–9739. 6 indexed citations
6.
Xin, Fuli, et al.. (2024). Bulk- and single cell-RNA sequencing reveal KIF20A as a key driver of hepatocellular carcinoma progression and immune evasion. Frontiers in Immunology. 15. 1469827–1469827. 2 indexed citations
7.
Ke, Qiao, Jian He, Fuli Xin, et al.. (2023). Resection Margin Width Does Not Influence the Prognosis of Solitary Hepatocellular Carcinoma After Anatomic Resection: A Real-World Study from China. Journal of Hepatocellular Carcinoma. Volume 10. 1353–1365. 4 indexed citations
10.
Wei, Zuwu, Fuli Xin, Sen Yang, et al.. (2022). Genetically Engineered Cell Membrane Modified Conjugated Polymer Nanoparticles for NIR‐II Photothermal Therapy. Advanced Materials Interfaces. 9(21). 11 indexed citations
11.
Chen, Feng, Lei He, Liman Qiu, et al.. (2021). Circular RNA CircEPB41L2 Functions as Tumor Suppressor in Hepatocellular Carcinoma Through Sponging miR-590-5p. Cancer Management and Research. Volume 13. 2969–2981. 11 indexed citations
12.
Zhang, Luwei, Fuli Xin, Zhixiong Cai, et al.. (2021). A colorimetric sensing platform for azodicarbonamide detection in flour based on MnO2 nanosheets oxidative system. Analytical and Bioanalytical Chemistry. 413(19). 4887–4894. 9 indexed citations
13.
Xin, Fuli, Ming Wu, Zhixiong Cai, et al.. (2021). Tumor Microenvironment Triggered Cascade‐Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular Carcinoma. Advanced Healthcare Materials. 10(10). e2002036–e2002036. 21 indexed citations
14.
Xin, Fuli, Ming Wu, Youshi Zheng, et al.. (2021). A remotely controlled NIR-II photothermal-sensitive transgene system for hepatocellular carcinoma synergistic therapy. Journal of Materials Chemistry B. 9(25). 5083–5091. 15 indexed citations
15.
Lin, Nanping, Jingrong Li, Qiao Ke, et al.. (2020). Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review. PLoS ONE. 15(3). e0229870–e0229870. 8 indexed citations
16.
Cai, Zhixiong, Geng Chen, Yongyi Zeng, et al.. (2019). Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma. Clinical Cancer Research. 25(17). 5284–5294. 115 indexed citations
19.
Cai, Zhixiong, Fuli Xin, Zuwu Wei, et al.. (2019). Photodynamic Therapy Combined with Antihypoxic Signaling and CpG Adjuvant as an In Situ Tumor Vaccine Based on Metal–Organic Framework Nanoparticles to Boost Cancer Immunotherapy. Advanced Healthcare Materials. 9(1). e1900996–e1900996. 145 indexed citations
20.
Wang, Lei, et al.. (2018). Metallothioneins may be a potential prognostic biomarker for tumors. Medicine. 97(52). e13786–e13786. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026